D. Sachdev

发表

Detection and downregulation of type I IGF receptor expression by antibody-conjugated quantum dots in breast cancer cells

Allison Hubel, D. Yee, Chun Wang, 2009, Breast Cancer Research and Treatment.

Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: implications for anti-insulin-like growth factor therapy in breast cancer.

D. Yee, Y. Fujita-Yamaguchi, D. Sachdev, 2006, Cancer research.

Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer

Jayanth Panyam, Da Yang, J. Panyam, 2019, Scientific Reports.

The IGF system and breast cancer.

D. Yee, D. Sachdev, 2001 .

Sequencing ofType I Insulin-Like Growth Factor Receptor Inhibition Affects Chemotherapy Response In vitro and In vivo

Hua Zhang, D. Sachdev, M. Gaillard-Kelly, 2009 .

Sequencing of Type I Insulin-Like Growth Factor Receptor Inhibition Affects Chemotherapy Response In vitro and In vivo

D. Yee, Hua Zhang, D. Sachdev, 2009, Clinical Cancer Research.

A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.

D. Yee, Shu-lian Li, Y. Fujita-Yamaguchi, 2003, Cancer research.

Role of IRS-1 Phosphorylation in IGF-1 and IL-4 Signaling in Breast Cancer

D. Sachdev, 2001 .

Combined Effects of Tamoxifen and a Chimeric Humanized Single Chain Antibody against the Type I IGF Receptor on Breast Tumor Growth In vivo

D. Yee, A. Wu, D. Ikle, 2003, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Disrupting insulin-like growth factor signaling as a potential cancer therapy

D. Yee, D. Sachdev, 2007, Molecular Cancer Therapeutics.

Inhibition of Cancer Cell Proliferation and Metastasis by Insulin Receptor Downregulation

D. Yee, Hua Zhang, D. Sachdev, 2010, Oncogene.

The type I insulin-like growth factor receptor regulates cancer metastasis independently of primary tumor growth by promoting invasion and survival

D. Yee, D. Sachdev, M. Gaillard-Kelly, 2009, Oncogene.

Regulation of Breast Cancer Metastasis by IGF Signaling

D. Sachdev, 2008, Journal of Mammary Gland Biology and Neoplasia.

A Dominant Negative Type I Insulin-like Growth Factor Receptor Inhibits Metastasis of Human Cancer Cells*

Adrian V. Lee, D. Yee, D. Sachdev, 2004, Journal of Biological Chemistry.

Acquired resistance to tamoxifen is associated with loss of the type I insulin-like growth factor receptor: implications for breast cancer treatment.

D. Yee, D. Sachdev, D. Fagan, 2012, Cancer research.

EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic mice.

D. Yee, D. Leroith, D. Sachdev, 2016, Endocrine-related cancer.

New Mechanisms of Signal Transduction Inhibitor Action

Steffi Oesterreich, Adrian V. Lee, Rachel Schiff, 2003 .

New mechanisms of signal transduction inhibitor action: receptor tyrosine kinase down-regulation and blockade of signal transactivation.

Steffi Oesterreich, Adrian V. Lee, Adrian V Lee, 2003, Clinical Cancer Research.

The IGF system and breast cancer.

D. Yee, D. Sachdev, M. Becker, 2001, Endocrine-related cancer.

SWIFT MRI enhances detection of breast cancer metastasis to the lung

M. Garwood, C. Corum, D. Sachdev, 2015, Magnetic resonance in medicine.

IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas

D. Yee, D. Sachdev, M. Cairo, 2015, PloS one.

Motility Response to Insulin-like Growth Factor-I (IGF-I) in MCF-7 Cells is Associated with IRS-2 Activation and Integrin Expression

D. Yee, F. Hakuno, Shin-ichiro Takahashi, 2004, Breast Cancer Research and Treatment.

Breast cancer cell-derived fibroblast growth factors enhance osteoclast activity and contribute to the formation of metastatic lesions

N. Brady, D. Sachdev, K. Schwertfeger, 2017, PloS one.

Inhibitors of Insulin-like Growth Factor Signaling: A Therapeutic Approach for Breast Cancer

D. Yee, D. Sachdev, 2006, Journal of Mammary Gland Biology and Neoplasia.

Drug evaluation: CP-751871, a human antibody against type I insulin-like growth factor receptor for the potential treatment of cancer.

D. Sachdev, 2007, Current opinion in molecular therapeutics.

Targeting the type I insulin-like growth factor system for breast cancer therapy.

D. Sachdev, 2010, Current drug targets.

A Novel Reduced Immunogenicity Bispecific Targeted Toxin Simultaneously Recognizing Human Epidermal Growth Factor and Interleukin-4 Receptors in a Mouse Model of Metastatic Breast Carcinoma

B. Stish, D. Sachdev, D. Vallera, 2009, Clinical Cancer Research.

Therapeutics , Targets , and Chemical Biology AcquiredResistance to Tamoxifen Is Associatedwith Loss of the Type I Insulin-like Growth Factor Receptor : Implications for Breast Cancer Treatment

D. Yee, D. Sachdev, D. Fagan, 2012 .